ArticleScientific reports2025

Risk of major adverse cardiovascular events and all-cause mortality in type 2 diabetic patients receiving insulin versus non-insulin treatment intensification.

Yu-Jie Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.